TCF20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.759800E-01
Normal-vs-Stage2
9.325400E-01
Normal-vs-Stage3
3.258200E-01
Normal-vs-Stage4
7.163000E-01
Stage1-vs-Stage2
8.796200E-01
Stage1-vs-Stage3
1.763160E-01
Stage1-vs-Stage4
6.849600E-01
Stage2-vs-Stage3
2.808800E-01
Stage2-vs-Stage4
6.385600E-01
Stage3-vs-Stage4
3.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.841800E-01
Normal-vs-AfricanAmerican
6.916600E-01
Normal-vs-Asian
7.117200E-01
Caucasian-vs-AfricanAmerican
4.919000E-01
Caucasian-vs-Asian
6.446400E-01
AfricanAmerican-vs-Asian
3.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.235000E-01
Normal-vs-Female
8.852000E-01
Male-vs-Female
8.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.689200E-01
Normal-vs-Age(41-60Yrs)
8.790200E-01
Normal-vs-Age(61-80Yrs)
8.183000E-01
Normal-vs-Age(81-100Yrs)
9.417200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.295200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.781600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.093200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.806780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.513000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.879400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.059600E-01
Normal-vs-Daily Drinker
7.026000E-01
Normal-vs-Weekly Drinker
6.230800E-01
Normal-vs-Occasional Drinker
6.820800E-01
Normal-vs-Social Drinker
7.389600E-01
Non Drinker-vs-Daily Drinker
9.129600E-01
Non Drinker-vs-Weekly Drinker
8.252800E-01
Non Drinker-vs-Occasional Drinker
3.320300E-02
Non Drinker-vs-Social Drinker
5.095200E-01
Daily Drinker-vs-Weekly Drinker
9.478400E-01
Daily Drinker-vs-Occasional Drinker
1.529230E-01
Daily Drinker-vs-Social Drinker
6.923200E-01
Weekly Drinker-vs-Occasional Drinker
1.229560E-01
Weekly Drinker-vs-Social Drinker
7.219000E-01
Occasional Drinker-vs-Social Drinker
1.926010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.767610E-01
Normal-vs-Grade 2
3.782200E-02
Normal-vs-Grade 3
6.051700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.715650E-01
Grade 1-vs-Grade 3
1.143390E-01
Grade 1-vs-Grade 4
1.767610E-01
Grade 2-vs-Grade 3
4.604600E-01
Grade 2-vs-Grade 4
3.782200E-02
Grade 3-vs-Grade 4
6.051700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.415000E-01
Normal-vs-NonDiabetic
8.397000E-01
Diabetic-vs-NonDiabetic
2.612000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.793600E-01
Normal-vs-NoPancreatitis
7.588600E-01
Pancreatitis-vs-NoPancreatitis
5.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.708200E-01
Normal-vs-N1
9.514200E-01
N0-vs-N1
7.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.560800E-01
Normal-vs-TP53-NonMutant
9.898800E-01
TP53-Mutant-vs-TP53-NonMutant
3.311900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
